ClinicalTrials.gg
Active, not recruitingNCT07940556VR-ADRGUpdated Nov 17, 2026

The Effect of Virtual Reality Glasses on Pain and Anxiety Levels During Abdominal Drain Removal After Gynecological Surgery

An interventional study of Virtual Reality (VR) Glasses in Postoperative Pain and Anxiety, sponsored by Çankırı Karatekin University. Active, not recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Çankırı Karatekin University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Aug 2026, registered Nov 2026).
Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 1,099 studies in Pain, Postoperative with a site in Turkey — 264 open to participants now, 297 under way, none of them phase 3. Pain, Postoperative · Turkey.

Enrollment
523rd of 884
60 · median 70
Started
2026
with 221 others
No phase
815 of 1,099
217 open now
Primary completion
2027-01
later than 198 of 296 live
Registered
1,097th of 1,099
by date

Among the 1,099 studies in Pain, Postoperative with a site in Turkey, this one is the 523rd largest by enrollment of the 884 interventional ones that give a count, is one of 222 that started in 2026, is one of 815 with no phase, reaches primary completion later than 198 of the 296 other live ones, and was the 1,097th registered.

Pain, Postoperative

5,654 studies on the registry are indexed under Pain, Postoperative; 1,233 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

264 of the 1,099 studies in Pain, Postoperative with a site in Turkey are open now. Recruiting first, the newest first:

259 more — sign in →

All 264 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 676 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 327 (48%) stop at 75 or younger; 74 take children under 18; 128 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,099 studies in Pain, Postoperative with a site in Turkey, or all of them as a file.
02

Study summary

Abdominal drain removal after gynecological surgery is a commonly performed procedure in female patients; however, it is often described by patients as a physically and psychologically challenging experience. During drain removal in the postoperative period, patients' pain and anxiety levels may increase.

Although pharmacological methods are effective, they may not always be sufficient on their own due to the risk of side effects and certain limitations. Therefore, it is important to investigate non-pharmacological methods and integrate them into nursing care.

This study aims to examine the effect of virtual reality glasses on pain and anxiety levels during abdominal drain removal after gynecological surgery.

The study will be conducted using a randomized controlled experimental design with parallel groups and pre-test/post-test measurements. The study sample will consist of 60 patients hospitalized in the Gynecologic Oncology Clinic of Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital. Patients will be assigned to an experimental group (n=30) or a control group (n=30).

Patients in the experimental group will watch 360-degree virtual reality videos featuring natural scenery for 10 minutes, beginning 5 minutes before abdominal drain removal. Patients in the control group will receive routine clinical care without any additional intervention.

Data will be collected using the Participant Information Form, Visual Analog Scale for Pain, State Anxiety Inventory, and Visual Analog Scale for Satisfaction.

The study is expected to contribute to improving patient comfort and integrating innovative non-pharmacological approaches into nursing care.

Read the detailed description

**Background and Rationale**

Abdominal drains are commonly used following gynecological surgery to monitor postoperative complications and facilitate postoperative care. However, the presence and removal of abdominal drains may cause physical discomfort, pain, and anxiety in patients. Drain removal, although a relatively short procedure, can be perceived as a painful and stressful experience.

Pharmacological approaches are frequently used for pain management; however, their potential side effects and limitations highlight the importance of non-pharmacological interventions. Virtual reality (VR) is an innovative non-pharmacological method that may reduce pain perception and anxiety by distracting patients' attention from painful stimuli and providing an immersive and relaxing environment.

Previous studies have demonstrated beneficial effects of virtual reality on pain and anxiety during various medical and surgical procedures, including chest tube removal, gynecological laparoscopy, and other invasive interventions. However, research specifically investigating the effects of virtual reality during abdominal drain removal following gynecological surgery remains limited.

**Objective**

This study aims to determine the effect of virtual reality glasses on patients' pain and anxiety levels during abdominal drain removal after gynecological surgery.

**Study Design and Setting**

This study will be conducted as a randomized controlled experimental study with a pretest-posttest, parallel-group design.

The research will be carried out in the Gynecologic Oncology Clinic of Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital in Türkiye.

A total of 60 patients who have undergone gynecological abdominal surgery and have an abdominal drain will be included. Participants will be randomly assigned to an experimental group (n=30) or a control group (n=30).

Stratified randomization based on patient age and diagnosis will be used to ensure homogeneity between the groups.

**Experimental Group**

Before the intervention, participants will complete the Participant Information Form. Baseline pain and anxiety levels will be assessed using the Visual Analog Scale for Pain (VAS) and the State Anxiety Inventory (STAI-State).

Five minutes before abdominal drain removal, patients will wear Oculus Quest 2 virtual reality glasses and watch 360-degree videos featuring natural scenery for a total of 10 minutes.

The virtual reality intervention will be administered in the patient's hospital room in a quiet environment. Patients will be allowed to select their preferred videos and control playback during the intervention.

Immediately after completion of the intervention, the virtual reality glasses will be removed. Pain and anxiety levels will be reassessed using the same measurement tools. Patient satisfaction with the virtual reality intervention will also be evaluated using the Visual Analog Scale for Satisfaction (VAS-S).

**Control Group**

Participants in the control group will receive routine clinical care without any additional intervention.

Before abdominal drain removal, baseline pain and anxiety levels will be assessed using the Visual Analog Scale for Pain and the State Anxiety Inventory.

Following abdominal drain removal, pain and anxiety levels will be reassessed using the same instruments.

**Data Collection and Statistical Analysis**

Data will be collected using the Participant Information Form, Visual Analog Scale for Pain, State Anxiety Inventory, and Visual Analog Scale for Satisfaction.

Statistical analysis will be performed using SPSS software. Descriptive statistics will include frequencies, percentages, means, and standard deviations.

Between-group comparisons will be conducted using the independent samples t-test or Mann-Whitney U test, while within-group comparisons will be performed using the paired samples t-test or Wilcoxon signed-rank test.

Correlation analysis will be performed to evaluate the relationship between pain and anxiety. Statistical significance will be set at p \< 0.05.

**Expected Contribution**

This study is expected to provide scientific evidence regarding the effectiveness of virtual reality as a non-pharmacological intervention for pain and anxiety management during abdominal drain removal following gynecological surgery.

The findings may contribute to improving patient comfort, supporting patient-centered nursing care, and integrating innovative technologies into postoperative nursing practices.

03

Conditions studied

  • Postoperative Pain
  • Anxiety

Keywords

  • Virtual Reality
  • Abdominal Drain Removal
  • Gynecological Surgery
  • Nursing Care
  • Non-Pharmacological Intervention
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 18 years or older.
  • Patients who voluntarily agreed to participate in the study.
  • Patients who were able to communicate without difficulty.
  • Patients who were able to read and understand Turkish.
  • Patients who underwent gynecological abdominal surgery.
  • Patients who had an abdominal drain following surgery.

Exclusion criteria

Exclusion Criteria:

  • Patients diagnosed with neuropsychiatric disorders.
  • Patients with chronic pain.
  • Patients who did not provide to participate in the study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Virtual Reality Group

    Patients in the experimental group (n=30) received a virtual reality intervention during abdominal drain removal after gynecological surgery. Oculus Quest 2 virtual reality glasses were applied 5 minutes before drain removal. Patients watched 360-degree videos featuring natural scenery for a total of 10 minutes. Pain and anxiety levels were assessed before and after the intervention using the Visual Analog Scale for Pain and the State Anxiety Inventory. Patient satisfaction with the virtual reality intervention was also evaluated.

    Device: Virtual Reality (VR) Glasses

  • No intervention
    Control Group

    Patients in the control group (n=30) received routine clinical care during abdominal drain removal after gynecological surgery. No additional intervention was performed. Pain and anxiety levels were assessed before and after abdominal drain removal using the Visual Analog Scale for Pain and the State Anxiety Inventory.

Interventions

  • DeviceVirtual Reality (VR) Glasses

    The intervention was performed using Oculus Quest 2 virtual reality glasses in the patients' own rooms in the gynecologic oncology clinic, in a quiet environment. The virtual reality glasses were placed on patients 5 minutes before abdominal drain removal. Patients watched 360-degree virtual reality videos featuring natural scenery for a total of 10 minutes. The videos were selected from YouTube, and slow-moving videos were preferred to minimize nausea and dizziness. Patients were allowed to select their preferred videos, switch between videos, pause playback, and restart the videos using the controls on the virtual reality headset. The virtual reality glasses were removed immediately after completion of the intervention.

06

What researchers measure

Primary outcomes

  1. Change in Pain Level

    Pain intensity was assessed using the Visual Analog Scale for Pain (VAS), ranging from 0 to 10. A score of 0 indicates no pain, scores of 1-3 indicate mild pain, scores of 4-6 indicate moderate pain, and scores of 7-10 indicate severe or unbearable pain. Higher scores indicate greater pain intensity. Pain levels were assessed before and after abdominal drain removal.

    Time frame: Before and immediately after abdominal drain removal

  2. Change in State Anxiety Level

    State anxiety was assessed using the 20-item State Anxiety Inventory (STAI-State). Each item is rated on a four-point Likert scale. Total scores range from 20 to 80, with higher scores indicating higher anxiety levels. Anxiety levels were assessed before and after abdominal drain removal.

    Time frame: Before and immediately after abdominal drain removal

  3. Patient Satisfaction With Virtual Reality

    Patient satisfaction with the virtual reality intervention was assessed using the Visual Analog Scale for Satisfaction (VAS-S), ranging from 0 to 10. A score of 0 indicates no satisfaction, while a score of 10 indicates the highest level of satisfaction. Higher scores indicate greater satisfaction. This outcome was assessed only in the experimental group.

    Time frame: Immediately after completion of the 10-minute virtual reality intervention

Secondary outcomes

  1. Patient Satisfaction With Virtual Reality

    Patient satisfaction with the virtual reality intervention was assessed using the Visual Analog Scale for Satisfaction (VAS-S). Patients rated their satisfaction on a scale from 0 to 10, where 0 indicates "not satisfied at all" and 10 indicates "very satisfied." Higher scores indicate greater satisfaction. Satisfaction was assessed only in the experimental group (n=30).

    Time frame: Immediately after completion of the 10-minute virtual reality intervention

07

Study locations

1 site
  • Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital
    Ankara, Yenimahalle 06200, Turkey (Türkiye)
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2026 (actual). Primary completion is estimated for Jan 2027, 5 months after the start.

Of 2,097 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 5 months is below that.

Counting every sponsor, half of 2,110 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 11, 2026
First posted
Nov 17, 2026
StartActual
Aug 1, 2026
Primary completionEst.
Jan 1, 2027
CompletionEst.
Jan 20, 2027
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07940556
Lead sponsor
Çankırı Karatekin University
Responsible party
İrem Coşkun (Master's Student in Women's Health and Obstetrics Nursing, Çankırı Karatekin University) — Principal investigator
First posted
Nov 17, 2026
Start date
Aug 1, 2026
Primary completion
Jan 1, 2027 (estimated)
Completion
Jan 20, 2027 (estimated)
Last update
Nov 17, 2026

Study contacts

Prof. Dr. Funda Atalay
study chair · Dr. Abdurrahman Yurtaslan Onkoloji Eğitim Araştırma Hastanesi

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion